SSRIs work by blocking the recycling of serotonin in the brain, leaving more of it available in the gaps between nerve cells. This single action sets off a cascade of slower changes, from receptor adaptation to the growth of new brain cells, that collectively improve mood over several weeks. About 11.4% of U.S. adults took prescription medication for depression in 2023, and SSRIs are the most widely prescribed class.
Serotonin Recycling and How SSRIs Stop It
When one nerve cell sends a signal to another, it releases serotonin into the tiny gap between them called the synaptic cleft. Under normal conditions, a transporter protein on the sending cell quickly vacuums that serotonin back up, ending the signal. This recycling process is called reuptake.
SSRIs bind to that transporter protein and block it. With the recycling channel occupied, serotonin lingers in the gap longer and continues stimulating the receiving cell. Unlike older antidepressants that affect multiple brain chemicals at once, SSRIs are highly selective: they have a strong affinity for the serotonin transporter, a low affinity for the norepinephrine transporter, and very little interaction with other neurotransmitter receptors. That selectivity is why they generally cause fewer side effects than older medications.
Why They Take Weeks to Work
The serotonin boost from an SSRI begins within hours of the first dose, yet most people don’t feel meaningfully better for several weeks. The delay puzzled researchers for years, but the current understanding involves two overlapping processes.
The first is autoreceptor desensitization. The sending cell has built-in sensors that detect serotonin levels and dial back its own firing when levels get too high. When you first start an SSRI, these sensors detect the sudden surplus and reduce serotonin output, partially canceling out the drug’s effect. Over days to weeks of continuous treatment, those sensors gradually lose sensitivity. Once they stop fighting the medication, serotonin neurons fire more freely and release more serotonin into target areas of the brain.
The second process is neurogenesis. Chronic SSRI use promotes the growth, survival, and maturation of new neurons in the hippocampus, a brain region involved in mood regulation and memory. This appears to happen through increased production of brain-derived neurotrophic factor (BDNF), a protein that supports nerve cell growth. SSRIs also cause existing mature neurons to shift into a more flexible, “immature-like” state, which may help the brain rewire mood circuits. Growing and integrating new neurons takes time, which helps explain why the full therapeutic benefit can lag behind the chemical changes.
Common SSRIs
Seven SSRIs are currently approved by the FDA. They share the same core mechanism but differ in how long they stay in the body, how they interact with other medications, and their side effect profiles. The most commonly prescribed include:
- Fluoxetine (Prozac): one of the longest-acting, often used when tapering off SSRIs
- Sertraline (Zoloft): widely prescribed for both depression and anxiety disorders
- Escitalopram (Lexapro): generally considered well-tolerated with fewer drug interactions
- Citalopram (Celexa)
- Paroxetine (Paxil): has mild anticholinergic effects, which makes its side effect profile slightly different
- Fluvoxamine (Luvox)
- Vilazodone (Viibryd)
As a class, SSRIs are approved for depression, anxiety, and other mood disorders. Individual medications may also carry approvals for obsessive-compulsive disorder, panic disorder, or post-traumatic stress disorder.
Why SSRIs Cause Digestive Side Effects
Nausea is the single most common side effect, affecting roughly 25% of people who start an SSRI. The reason is straightforward: most of the body’s serotonin is not in the brain. It’s produced by specialized cells lining the gut, and the same transporter protein that SSRIs block in the brain also exists throughout the digestive tract. When the drug raises serotonin availability in the gut, it overstimulates receptors there.
Elevated gut serotonin activates receptors on nerve endings that send signals to the brain’s vomiting center, triggering nausea. A different set of receptors speeds up the contractions that move food through the intestines, which can cause diarrhea or loose stools. Paroxetine is a partial exception: it has mild anticholinergic activity (meaning it also blocks a different signaling pathway in the gut), so it’s more likely to cause constipation than diarrhea.
These digestive effects are usually worst in the first week or two and tend to fade as the body adjusts. They are also the leading cause of people stopping their medication early, before the mood benefits have had time to develop.
Other Side Effects
Beyond digestive symptoms, SSRIs can cause headaches, sleep disturbances (either drowsiness or insomnia, depending on the person and the specific drug), sexual side effects like reduced desire or difficulty reaching orgasm, and mild weight changes. Most side effects are dose-dependent, meaning they’re more likely at higher doses, and many diminish over the first few weeks of treatment.
What Happens When You Stop
Stopping an SSRI abruptly can trigger discontinuation syndrome, a set of symptoms that differ from a return of depression. Common complaints include dizziness, flu-like body aches, digestive upset, and “brain zaps,” a sensation often described as a brief electric shock or shiver inside the head. Mood disturbances like irritability, anxiety, and agitation can also occur.
These symptoms arise because the brain has adapted to a sustained higher level of serotonin signaling, and a sudden drop forces rapid readjustment. The standard approach is to taper the dose gradually over weeks to months, reducing it in increments with two to six weeks between each step. Shorter-acting SSRIs (like paroxetine) are more likely to cause discontinuation symptoms than longer-acting ones (like fluoxetine). In some cases, a doctor will temporarily switch a patient to fluoxetine before tapering, because its longer duration in the body creates a built-in, gentler decline.
Keeping a daily mood log during the tapering period, rating your mood on a simple 1-to-10 scale, can help you and your provider distinguish between discontinuation symptoms and a genuine return of depression. Timing matters too: starting a taper during a period of high stress or major life change increases the risk of a rough transition.